Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-kappaB activities - PubMed (original) (raw)
Helix-loop-helix proteins regulate pre-TCR and TCR signaling through modulation of Rel/NF-kappaB activities
Dongsoo Kim et al. Immunity. 2002 Jan.
Free article
Abstract
E2A and HEB are basic helix-loop-helix transcription factors essential for T cell development. Complete inhibition of their activities through transgenic overexpression of their inhibitors Id1 and Tal1 leads to a dramatic loss of thymocytes. Here, we suggest that bHLH proteins play important roles in establishing thresholds for pre-TCR and TCR signaling. Inhibition of their function allows double-negative cells to differentiate without a functional pre-TCR, while anti-CD3 stimulation downregulates bHLH activities. We also find that the transcription factor NF-kappaB becomes activated in transgenic thymocytes. Further activation of NF-kappaB exacerbates the loss of thymocytes, whereas inhibition of NF-kappaB leads to the rescue of double-positive thymocytes. Therefore, we propose that E2A and HEB negatively regulate pre-TCR and TCR signaling and their removal causes hyperactivation and apoptosis of thymocytes.
Similar articles
- Hyperresponse to T-cell receptor signaling and apoptosis of Id1 transgenic thymocytes.
Qi Z, Sun XH. Qi Z, et al. Mol Cell Biol. 2004 Sep;24(17):7313-23. doi: 10.1128/MCB.24.17.7313-7323.2004. Mol Cell Biol. 2004. PMID: 15314144 Free PMC article. - Id1 potentiates NF-kappaB activation upon T cell receptor signaling.
Yang Y, Liou HC, Sun XH. Yang Y, et al. J Biol Chem. 2006 Nov 17;281(46):34989-96. doi: 10.1074/jbc.M608078200. Epub 2006 Sep 29. J Biol Chem. 2006. PMID: 17012234 - A novel role for HEB downstream or parallel to the pre-TCR signaling pathway during alpha beta thymopoiesis.
Barndt R, Dai MF, Zhuang Y. Barndt R, et al. J Immunol. 1999 Sep 15;163(6):3331-43. J Immunol. 1999. PMID: 10477603 - Inefficient ZAP-70 phosphorylation and decreased thymic selection in vivo result from inhibition of NF-kappaB/Rel.
Mora AL, Stanley S, Armistead W, Chan AC, Boothby M. Mora AL, et al. J Immunol. 2001 Nov 15;167(10):5628-35. doi: 10.4049/jimmunol.167.10.5628. J Immunol. 2001. PMID: 11698434 - [The Rel/NF-kappa B transcription factors and their biological functions].
Kankova K, Vojtesek B, Valík D. Kankova K, et al. Cas Lek Cesk. 2001 Mar 29;140(6):163-7. Cas Lek Cesk. 2001. PMID: 11347205 Review. Czech.
Cited by
- Dynamic changes in E-protein activity regulate T reg cell development.
Gao P, Han X, Zhang Q, Yang Z, Fuss IJ, Myers TG, Gardina PJ, Zhang F, Strober W. Gao P, et al. J Exp Med. 2014 Dec 15;211(13):2651-68. doi: 10.1084/jem.20132681. Epub 2014 Dec 8. J Exp Med. 2014. PMID: 25488982 Free PMC article. - Increased level of E protein activity during invariant NKT development promotes differentiation of invariant NKT2 and invariant NKT17 subsets.
Hu T, Wang H, Simmons A, Bajaña S, Zhao Y, Kovats S, Sun XH, Alberola-Ila J. Hu T, et al. J Immunol. 2013 Nov 15;191(10):5065-73. doi: 10.4049/jimmunol.1301546. Epub 2013 Oct 11. J Immunol. 2013. PMID: 24123679 Free PMC article. - E-Protein Inhibition in ILC2 Development Shapes the Function of Mature ILC2s during Allergic Airway Inflammation.
Barshad G, Webb LM, Ting HA, Oyesola OO, Onyekwere OG, Lewis JJ, Rice EJ, Matheson MK, Sun XH, von Moltke J, Danko CG, Tait Wojno ED. Barshad G, et al. J Immunol. 2022 Mar 1;208(5):1007-1020. doi: 10.4049/jimmunol.2100414. Epub 2022 Feb 18. J Immunol. 2022. PMID: 35181641 Free PMC article. - A recurrent dominant negative E47 mutation causes agammaglobulinemia and BCR(-) B cells.
Boisson B, Wang YD, Bosompem A, Ma CS, Lim A, Kochetkov T, Tangye SG, Casanova JL, Conley ME. Boisson B, et al. J Clin Invest. 2013 Nov;123(11):4781-5. doi: 10.1172/JCI71927. J Clin Invest. 2013. PMID: 24216514 Free PMC article. - Downregulation of E Protein Activity Augments an ILC2 Differentiation Program in the Thymus.
Wang HC, Qian L, Zhao Y, Mengarelli J, Adrianto I, Montgomery CG, Urban JF Jr, Fung KM, Sun XH. Wang HC, et al. J Immunol. 2017 Apr 15;198(8):3149-3156. doi: 10.4049/jimmunol.1602009. Epub 2017 Mar 3. J Immunol. 2017. PMID: 28258196 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- R01 AI033597/AI/NIAID NIH HHS/United States
- RR15577/RR/NCRR NIH HHS/United States
- CA77553/CA/NCI NIH HHS/United States
- P20 RR015577/RR/NCRR NIH HHS/United States
- AI33443/AI/NIAID NIH HHS/United States
- AI33597/AI/NIAID NIH HHS/United States
- R01 AI033443/AI/NIAID NIH HHS/United States
- R01 CA077553/CA/NCI NIH HHS/United States